Please assess the completion status of the following clinical trial:

Trial Title: BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Patient inclusion criteria:~* Patients with at least two matched bilateral deep carious primary molars indicated for pulpotomy.~* Patients within the age group of four to eight years.~* Healthy patients (both physically and mentally) without any known medical history of systemic conditions contraindicating pulp treatment.~* Cooperative patients who had behavioral ratings positive or definitely positive according to the Frankl behavior classification scale.~* Written consent was obtained from the parent/guardian after explaining the full details of the treatment procedure and its possible outcomes, discomforts, risks, and benefits.~* No patients were excluded on the basis of gender, race, social or economic background.~Patients not satisfying any of the above-mentioned criteria were excluded from the study.~Teeth inclusion criteria:~Teeth were selected based upon the following clinical and radiographic criteria: Clinically, the study included teeth with restorable crowns, teeth with pathologic carious or mechanical exposure of vital pulps and teeth with no clinical symptoms or evidence of pulp degeneration, such as spontaneous or nocturnal pain, pain on percussion, history of swelling, or sinus tracts and teeth with no tenderness to percussion, physiologic or pathologic mobility. Radiographically, the recruited teeth should have a normal radiographic appearance with healthy supporting tissues, no signs of internal resorption, or pathologic external root resorption and no periapical or inter-radicular pathosis, with at least two-thirds of the root remaining (not more than one-third of the root is physiologically resorbed).~Teeth exclusion criteria:~Teeth were excluded if (1) any of the above-mentioned clinical or radiographic inclusion criteria were not satisfied, (2) hemostasis could not be achieved within 5 minutes by direct contact with a wet cotton pellet, prior to material placement, or (3) the remaining radicular tissue was non-vital (with suppuration or purulence necrosis).

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 8 Years
- Healthy Volunteers: t

Study Arms:
- BiodentineTM pulpotomy group (Type: EXPERIMENTAL): A Bioactive Dentine Substitute (BiodentineTM, Septodont Ltd., Saint Maur des Faussés, France) was used following the manufacturer's recommendations. The whole pulp chamber was entirely filled with BiodentineTM until the occlusal surface.
- Formocresol pulpotomy group (Type: ACTIVE_COMPARATOR): A sterile cotton pellet moistened with 1:5 concentration formocresol (Buckley's Formocresol, Sultan Healthcare, Englewood, NJ, USA) then blotted to remove excess was placed for 5 minutes on the pulp stumps and then the pulps were covered with zinc oxide-eugenol (IRM; Dentsply, Milford, DE) dressing.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete